Spots Global Cancer Trial Database for cddp
Every month we try and update this database with for cddp cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma | NCT02532192 | Lymphoma | Belinostat Rituximab Cisplatin Cytarabine Dexamethasone Ciprofloxacin Fluconazole | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract | NCT00353015 | Gastrointestina... Carcinoma, Neur... | Cisplatin Irinotecan | - | M.D. Anderson Cancer Center | |
| Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer | NCT00388154 | Endometrial Can... | Gemcitabine Cisplatin | - | M.D. Anderson Cancer Center | |
| Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy | NCT01998529 | Lung Cancer | Cisplatin Amifostine | 3 Years - 21 Years | M.D. Anderson Cancer Center | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma | NCT03914443 | Locally Advance... | Nivolumab 5-FU CDDP DTX | 20 Years - 75 Years | National Cancer Center, Japan | |
| Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT01154920 | Head and Neck S... | Paclitaxel Carboplatin Cetuximab Docetaxel Cisplatin Fluorouracil Radiotherapy (R... Chemotherapy | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy | NCT01998529 | Lung Cancer | Cisplatin Amifostine | 3 Years - 21 Years | M.D. Anderson Cancer Center | |
| Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor | NCT01277744 | Advanced Cancer... Sarcoma | Hyperthermic Pe... Cisplatin | 1 Year - | M.D. Anderson Cancer Center | |
| A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005 | NCT01047007 | Solid Tumors | adavosertib 20 ... 5-FU 1000 mg/m^... CDDP adavosertib 65 ... | 20 Years - | Merck Sharp & Dohme LLC | |
| OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer | NCT00076310 | Head and Neck C... | Docetaxel OSI-774 Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement | NCT00507962 | Advanced Cancer | Cisplatin Liposomal Doxor... | - | M.D. Anderson Cancer Center | |
| Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma | NCT00970996 | Melanoma | Temozolomide Abraxane Cisplatin Interleukin-2 Interferon alph... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract | NCT00353015 | Gastrointestina... Carcinoma, Neur... | Cisplatin Irinotecan | - | M.D. Anderson Cancer Center | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma | NCT03914443 | Locally Advance... | Nivolumab 5-FU CDDP DTX | 20 Years - 75 Years | National Cancer Center, Japan | |
| Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas | NCT02263105 | High-grade Glio... | CDDP Temozolomide | 18 Years - 75 Years | Huashan Hospital | |
| Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor | NCT01277744 | Advanced Cancer... Sarcoma | Hyperthermic Pe... Cisplatin | 1 Year - | M.D. Anderson Cancer Center | |
| Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors | NCT00984997 | Lung Cancer | Surgery Chest Irradiati... Cisplatin Etoposide Prophylactic Cr... | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement | NCT00507962 | Advanced Cancer | Cisplatin Liposomal Doxor... | - | M.D. Anderson Cancer Center | |
| Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | NCT00512096 | Penile Cancer | Ifosfamide Paclitaxel (Tax... Cisplatin | 14 Years - | M.D. Anderson Cancer Center | |
| Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer | NCT00436657 | Peritoneal Neop... Retroperitoneal... Gastrointestina... Adenocarcinoma Neuroblastoma Ovarian Neoplas... Sarcoma Adrenocortical ... Wilms Tumor Rhabdomyosarcom... Desmoplastic Sm... | CHPP of Cisplat... Abdominal Surge... | 3 Years - 18 Years | M.D. Anderson Cancer Center | |
| Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma | NCT00402766 | Mesothelioma | Cisplatin Imatinib Mesyla... Pemetrexed Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma | NCT00970996 | Melanoma | Temozolomide Abraxane Cisplatin Interleukin-2 Interferon alph... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma | NCT01409174 | Melanoma | Ipilimumab Temozolomide Cisplatin Interferon Alfa... Interleukin-2 | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | NCT00512096 | Penile Cancer | Ifosfamide Paclitaxel (Tax... Cisplatin | 14 Years - | M.D. Anderson Cancer Center | |
| Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer | NCT00546130 | Small Cell Lung... | Irinotecan hydr... Cisplatin Krestin | 20 Years - 74 Years | University of Toyama | |
| A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma | NCT03914443 | Locally Advance... | Nivolumab 5-FU CDDP DTX | 20 Years - 75 Years | National Cancer Center, Japan | |
| Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer | NCT02092298 | Gastrointestina... | Mitomycin C Cisplatin Sodium Thiosulf... | 18 Years - | M.D. Anderson Cancer Center | |
| Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors | NCT00984997 | Lung Cancer | Surgery Chest Irradiati... Cisplatin Etoposide Prophylactic Cr... | 18 Years - 70 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
